Search Results - M. Rimini
- Showing 1 - 2 results of 2
-
1
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment by F. Rossari, D. Lavacchi, E. Alimenti, C. Soldà, F. Salani, L. Esposito, S. Foti, S. Camera, M. Persano, F. Lo Prinzi, F. Vitiello, E. Pellegrini, M. Bruccoleri, M.D. Rizzato, M. Caccese, I.G. Rapposelli, A. Guidolin, A. De Rosa, L. Antonuzzo, G. Masi, M.A. Iavarone, S. Lonardi, M. Rimini, A. Casadei-Gardini
Published in ESMO Gastrointestinal Oncology (2025-06-01)Get full text
Article -
2
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience by M. Rimini, S. Presi, K. Mohammadi, G.B. Pipitone, A.R. Raucci, F. Ratti, F. Pedica, S. Foti, S. Camera, M. Ferrara, L. Passeri, G. Vanella, F. Rossari, F. Lo Prinzi, M. Persano, F. Vitiello, M.G. Cangi, L. Pecciarini, P.G. Arcidiacono, F. Falcinelli, F. De Cobelli, L. Aldrighetti, M.G. Patricelli, P. Carrera, A. Casadei-Gardini
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article
